Hypermarcas (OTCMKTS:HYPMY) Short Interest Update
by Teresa Graham · The Cerbat GemHypermarcas (OTCMKTS:HYPMY – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 3,352 shares, a drop of 94.7% from the April 30th total of 63,443 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average trading volume of 57,615 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy”.
View Our Latest Analysis on HYPMY
Hypermarcas Stock Up 0.2%
Shares of HYPMY stock traded up $0.01 during trading hours on Thursday, hitting $4.42. 26,253 shares of the company were exchanged, compared to its average volume of 25,506. The business has a 50 day moving average of $4.53 and a two-hundred day moving average of $4.51. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. Hypermarcas has a 52 week low of $3.71 and a 52 week high of $5.50. The company has a market capitalization of $3.11 billion, a PE ratio of 9.21 and a beta of 0.73.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The company had revenue of $383.13 million during the quarter. Analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current fiscal year.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.